Rebyota

Generic name: (fecal Microbiota, Live-jslm)
Dosage form: suspension, for rectal use
Drug class: Miscellaneous uncategorized agents

Usage of Rebyota

Rebyota is a fecal microbiota product used for the prevention of recurrence of Clostridioides difficile infection (CDI).

Rebyota is a fecal transplant product manufactured from human fecal matter donated by screened individuals. It works by facilitating the restoration of the gut flora to prevent further episodes of Clostridioides difficile infection.

Rebyota is administered rectally 24 to 72 hours after the last dose of antibiotics for the treatment of recurrent CDI.

Rebyota is not indicated for treatment of CDI.

Rebyota has not been studied in patients below 18 years of age.

Rebyota side effects

Common side effects may include:

stomach pain

diarrhea,

bloating,

gas, and

nausea.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-332-1088.

Before taking Rebyota

Before you receive Rebyota, tell your doctor if you have any food allergies. Rebyota is manufactured from human fecal matter and may contain food allergens, although the potential for the product to cause adverse reactions due to food allergens is unknown.

Appropriate medical treatment must be immediately available in case you experience an allergic reaction.

Relate drugs

How to use Rebyota

Usual Adult Dose for Prevention of Recurrent Clostridioides difficile Infection:

150 mL administered rectally as a single dose

Use: prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older, following antibiotic treatment for recurrent CDI.

Warnings

You should not receive Rebyota if you have a history of a severe allergic reaction to Rebyota or any of its components.

You should report to your doctor if you think you may have acquired any infection after administration. Rebyota is manufactured from human fecal matter and may carry a risk of transmitting infectious agents.

You should talk to your doctor about any known food allergies and be prepared should you experience any reaction. Rebyota is manufactured from human fecal matter and may contain food allergens.

You should not take any oral antibiotic therapy for up to 8 weeks after receiving Rebyota.

What other drugs will affect Rebyota

You should not take any oral antibiotic therapy for up to 8 weeks after receiving Rebyota unless directed by your doctor.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.